Shaeer's Vein Ligation-II: Internal Pudendal Vein Perineal Ligation For Veno Occlusive Erectile Dysfunction
Launched by KASR EL AINI HOSPITAL · Nov 6, 2023
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, known as Shaeer's Vein Ligation-II, is investigating a new surgical technique to help men who experience erectile dysfunction (ED) due to a specific blood flow issue called deep system veno-occlusive erectile dysfunction. The study aims to find out if this surgery can improve the firmness of erections, how satisfied patients are after the procedure, and if there are any complications.
To participate, men must have tried other treatments for ED without success, such as pills, hormone therapy, or injections, and still struggle with getting an erection. However, those with uncontrolled diabetes, certain other health conditions, or who smoke will not be eligible. Participants will either have the new surgical technique or a standard surgery and will need to share their results for at least six months. This trial is still in the planning stage and has not started recruiting participants yet.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male patients with deep system veno-occlusive erectile dysfunction
- • Lack of response to medical treatment for erectile dysfunction including PDEi (Phosphodiesterase Inhibitors), aphrodisiacs, hormonal therapy (if there is a hormonal disturbance), and intracavernous injections, despite control of risk factors such as diabetes mellitus.
- Exclusion Criteria:
- • Patients with uncontrolled diabetes, smokers and patients with anesthesia risk
- • Patients with arteriogenic erectile dysfunction, penile fibrosis, Peyronie's disease or psychiatric disorders.
- • Patients with bilateral deep system VOD
- • Patients who refuse to participate in the study
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Osama Shaeer, MD,PhD
Study Chair
kasr El Aini Faculty of Medicine, Cairo University, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported